The Lockwood Group

About The Lockwood Group

The Lockwood Group is a healthcare services platform delivering integrated, science-first solutions across the life sciences landscape. Through a network of specialized operating companies — Lockwood, Random42, Nexus Health, APS, Stratis, IDEOlogy Health, Research to Practice, and Total Health Oncology — we offer a comprehensive suite of capabilities spanning medical communications, publications, education, animation and visualization, regulatory and clinical consulting, and market access. Our integrated model enables pharmaceutical and biotechnology companies to access deep therapeutic expertise and creative excellence across a single, connected platform, with a focus in oncology and rare disease. Whether supporting early pipeline strategy or late-stage commercialization, we translate complex science into clear, compelling solutions that accelerate readiness, engage stakeholders, and drive meaningful impact. Science is at the core of everything we do. We partner with innovators who are changing the lives of patients — and we bring the rigor, strategy, and creativity to help them succeed.